Leishmania major inhibits IL-12 in macrophages by signalling through CR3 (CD11b/CD18) and down-regulation of ETS-mediated transcription.
Leishmania major inhibits IL-12 in macrophages by signalling through CR3 (CD11b/CD18) and down-regulation of ETS-mediated transcription.
复制标题
重大利什曼原虫通过 CR3 (CD11b/CD18) 信号传导和 ETS 介导的转录下调来抑制巨噬细胞中的 IL-12。
DOI:
10.1111/pim.12049
复制
发表时间:
2013
影响因子:
2.2
通讯作者:
McDowell,MA
中科院分区:
文献类型:
--
作者:
Ricardo-Carter,C;Favila,M;Polando,RE;Cotton,RN;BogardHorner,K;Condon,D;Ballhorn,W;Whitcomb,JP;Yadav,M;Geister,RL;Schorey,JS;McDowell,MA
Leishmania majoris an aetiological agent of cutaneous leishmaniasis. The parasite primarily infects immune sentinel cells, specifically macrophages and dendritic cells, in the mammalian host. Infection is receptor mediated and is known to involve parasite binding to cell surface protein complement receptor 3 (CR3, Mac‐1, CD11b/CD18). Engagement of CR3 by various ligands inhibits production of interleukin‐12 (IL‐12), the cytokine that drives antileishmanial T helper 1‐type immune responses. Likewise,L. majorinfection inhibits IL‐12 production and activation of host macrophages. Our data indicate that in the absence of CR3,L. major‐infected bone marrow‐derived macrophages produce more IL‐12 and nitric oxide compared with WT cells upon lipopolysaccharide (LPS) stimulation. We therefore investigated multiple signalling pathways by whichL. majormay inhibit IL‐12 transcription through CR3 ligation. We demonstrate thatL. majorinfection does not elicit significant NFκB p65, MAPK, IRF‐1 or IRF‐8 activation in WT or CD11b‐deficient macrophages. Furthermore, infection neither inhibits LPS‐induced MAPK or NFκB activation nor blocks IFN‐γ‐activated IRF‐1 and IRF‐8. ETS‐mediated transcription, however, is inhibited byL. majorinfection independently of CR3. Our data indicate thatL. major‐mediated inhibition of IL‐12 occurs through CR3 engagement; however, the mechanism of inhibition is independent of NFκB, MAPK, IRF and ETS.